According to Gram Research analysis, elevated vitamin B12 levels are associated with significantly higher death rates in hospitalized dementia patients. A 2026 cohort study of 33,026 dementia patients found that those with B12 levels above 900 pg/mL had a 10.9% death rate within 90 days compared to 8.3% for those with normal B12 levels—representing a 36% increase in mortality risk. High B12 was also linked to serious infections like sepsis and pneumonia, suggesting it may serve as a warning sign in vulnerable hospitalized populations.
A new study of over 16,000 hospitalized dementia patients found something surprising: those with very high vitamin B12 levels had a higher risk of dying within 90 days compared to those with normal B12 levels. Researchers discovered that elevated B12 was also connected to serious infections like sepsis and pneumonia, as well as needing intensive care. While this finding seems backwards—since B12 is usually considered healthy—it suggests that extremely high B12 levels might be a warning sign that doctors should pay attention to in vulnerable dementia patients.
Key Statistics
A 2026 cohort study of 33,026 hospitalized dementia patients found that elevated vitamin B12 levels (≥900 pg/mL) were associated with a 10.9% death rate within 90 days compared to 8.3% for patients with normal B12 levels, representing a 36% increased odds of mortality.
According to research reviewed by Gram, elevated B12 in hospitalized dementia patients was linked to sepsis in 4.2% of cases versus 3.0% in normal B12 groups, and pneumonia in 8.3% versus 6.6%, suggesting high B12 is a marker for serious infections.
A 2026 analysis of 33,026 hospitalized dementia patients showed that those with elevated B12 levels were 31% more likely to require intensive care unit admission (3.9% versus 3.0%), indicating more severe illness overall.
The 2026 cohort study found no association between elevated B12 and urinary tract infections, suggesting the B12 connection is specific to certain types of serious infections rather than all infections in dementia patients.
The Quick Take
- What they studied: Whether very high vitamin B12 levels in the blood are connected to worse health outcomes in older adults with dementia who are in the hospital
- Who participated: 33,026 hospitalized adults with dementia (16,513 in each comparison group) admitted between 2010-2024. Researchers matched patients with high B12 levels (900 or above) to similar patients with normal B12 levels (300-900) to make fair comparisons
- Key finding: Patients with elevated B12 had a 10.9% death rate within 90 days versus 8.3% for those with normal B12 levels—meaning high B12 was linked to about 30% higher odds of dying
- What it means for you: If you have a family member with dementia in the hospital, unusually high B12 levels might be a red flag worth discussing with doctors. However, this doesn’t mean B12 supplements are dangerous—the study only looked at people already hospitalized with dementia, not healthy people taking supplements
The Research Details
Researchers looked back at medical records from 2010-2024 for hospitalized dementia patients who had their B12 levels checked within a week of admission. They divided patients into two groups: those with very high B12 (900 or above) and those with normal B12 (300-900). To make a fair comparison, they used a statistical technique called propensity score matching, which is like pairing up similar patients from each group based on age, other health conditions, and lab results. This helps ensure that differences in outcomes are due to B12 levels, not other factors.
The researchers then tracked what happened to these patients over the next 90 days, looking at who died, who got serious infections, and who needed intensive care. They also did extra analyses to make sure their findings held up when they looked at specific subgroups of patients.
This research approach is important because it helps identify warning signs in vulnerable hospital patients. By using propensity score matching, the researchers could compare similar patients fairly, making it more likely that the B12 connection is real rather than just a coincidence. The large sample size (over 33,000 patients) also makes the findings more reliable than smaller studies
This is a well-designed observational study with a large sample size and careful statistical matching. The findings were consistent across multiple sensitivity analyses, meaning the results held up even when researchers looked at the data different ways. However, because it’s observational rather than experimental, we can’t be 100% certain that high B12 causes worse outcomes—it might be a marker of something else going wrong. The researchers themselves note that future prospective studies are needed to confirm these findings
What the Results Show
The main finding was striking: patients with elevated B12 levels had significantly higher 90-day mortality rates. Specifically, 10.9% of patients with high B12 died within 90 days compared to 8.3% of those with normal B12 levels. This translates to an odds ratio of 1.36, meaning patients with high B12 had about 36% higher odds of dying.
Beyond mortality, elevated B12 was also linked to serious infections. Sepsis (a life-threatening blood infection) occurred in 4.2% of the high B12 group versus 3.0% in the normal B12 group. Pneumonia was also more common: 8.3% versus 6.6%. Additionally, patients with high B12 were more likely to need intensive care unit admission (3.9% versus 3.0%).
Interestingly, urinary tract infections showed no significant association with B12 levels, suggesting that the B12 connection is specific to certain types of infections rather than all infections. These patterns remained consistent when researchers looked at different subgroups of dementia patients, strengthening confidence in the findings.
The study found that elevated B12 was particularly associated with serious bacterial infections (sepsis and pneumonia) rather than urinary tract infections. This pattern suggests that high B12 might be a marker of a specific type of immune system problem or underlying infection process. The consistent link to ICU admission indicates that high B12 patients were sicker overall and needed more intensive medical support
This research adds to a growing body of evidence showing that extremely high B12 levels—once thought to be harmless—can actually be a warning sign in hospitalized patients. Previous studies in other patient populations have noted this paradoxical relationship, but this is the first study to specifically examine it in dementia patients, who are particularly vulnerable. The findings suggest that B12 levels might work differently in elderly dementia patients compared to younger, healthier populations
This study has several important limitations. First, it’s observational, meaning researchers watched what happened rather than randomly assigning people to different B12 levels. This means we can’t prove that high B12 causes worse outcomes—it might just be a marker of other serious health problems. Second, the study only included hospitalized patients with dementia, so the findings may not apply to people with dementia living at home or to people without dementia. Third, the researchers couldn’t determine why high B12 was associated with worse outcomes. Finally, the study doesn’t tell us anything about whether B12 supplements are safe for healthy people or those with dementia living outside hospitals
The Bottom Line
For hospitalized dementia patients: doctors should pay attention to unusually high B12 levels as a potential warning sign and monitor these patients closely for infections and complications (moderate confidence). For people taking B12 supplements: this study doesn’t suggest you should stop taking supplements, as it only looked at hospitalized patients with dementia (low applicability). For caregivers: if your family member with dementia is hospitalized and has high B12 levels, discuss this finding with their medical team (moderate confidence)
Hospital doctors and nurses caring for dementia patients should be aware of this finding. Caregivers of hospitalized dementia patients may want to ask about B12 levels if their loved one seems to be declining. People taking B12 supplements for general health should not be concerned based on this study, as it only applies to hospitalized dementia patients. Researchers studying dementia and aging should consider investigating why high B12 appears to be a risk marker
The outcomes measured in this study occurred within 90 days of hospital admission, so any risks associated with elevated B12 would likely appear relatively quickly in hospitalized patients. For people taking B12 supplements, there’s no evidence from this study of any short-term or long-term risks
Frequently Asked Questions
Does high vitamin B12 mean I’m going to die if I’m in the hospital with dementia?
High B12 is associated with increased risk, but it doesn’t mean death is certain. In this study, 10.9% of patients with high B12 died within 90 days versus 8.3% with normal B12. This means high B12 is a warning sign doctors should monitor closely, not a death sentence.
Should I stop taking B12 supplements because of this study?
This study only looked at hospitalized dementia patients, not healthy people taking supplements. There’s no evidence from this research that B12 supplements are dangerous for the general population. Discuss any concerns about supplements with your doctor.
Why would high B12 be bad when B12 is usually considered healthy?
Researchers don’t yet know why extremely high B12 levels are associated with worse outcomes in hospitalized dementia patients. High B12 might be a marker of underlying serious illness rather than the cause of problems. More research is needed to understand the mechanism.
What should I do if my family member with dementia has high B12 in the hospital?
Ask the medical team about the B12 result and request closer monitoring for infections and complications. Watch for signs of sepsis, pneumonia, or other serious infections. This finding suggests doctors should pay extra attention to patients with elevated B12 levels.
Is this study proof that high B12 causes death in dementia patients?
No. This is an observational study, meaning researchers watched what happened rather than conducting an experiment. High B12 might be a marker of other serious health problems rather than a direct cause. Future studies are needed to confirm these findings.
Want to Apply This Research?
- If a family member with dementia is hospitalized, track their B12 lab results when available and note any infections, ICU admissions, or health changes that occur within the 90-day period following admission
- When visiting a hospitalized family member with dementia, ask the medical team about recent lab results including B12 levels, and request more frequent monitoring if B12 is elevated
- Create a simple log documenting hospital admission date, B12 level (if available), any infections that develop, ICU stays, and 90-day outcome. Share this information with the medical team to support better care decisions
This research applies specifically to hospitalized patients with dementia and should not be interpreted as medical advice for the general population or for people taking B12 supplements. The study is observational and cannot prove that high B12 causes worse outcomes. If you or a family member has concerns about B12 levels or dementia care, consult with a qualified healthcare provider. This article is for educational purposes only and does not replace professional medical guidance.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.